(Q41641426)

6 October 2017

title

Treatment of intractable ascites in patients with alcoholic cirrhosis by peritoneovenous shunting (LeVeen) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449438

2 July 2022

Treatment of Intractable Ascites in Patients with Alcoholic Cirrhosis by Peritoneovenous Shunting (LeVeen) (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

17 May 2023

author name string

M. M. Stanley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A449438

2 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=449438

2 July 2022

publication date

1 May 1979

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:S0025712516316856?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

https://api.elsevier.com/content/article/PII:S0025712516316856?httpAccept=text/plain

17 May 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Medical Clinics of North America

17 May 2023

published in

1 reference

6 October 2017

volume

63

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

523-536

1 reference

Renal failure in advanced liver disease

6 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Endogenous Creatinine Clearance as a Clinical Measure of Glomerular Filtration Rate

17 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Hepatorenal syndrome: reversal by peritoneovenous shunt

17 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Negative influences of ascites on the cardiac function of cirrhotic patients

17 May 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Peritoneo-venous shunting for ascites

17 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Further experience with peritoneo-venous shunt for ascites

17 May 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Some aspects of circulatory disturbances in cirrhosis of the liver

17 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Peritoneo-venous shunting for ascites

17 May 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

LaVeen continuous peritoneal-jugular shunt. Improvement of renal function in ascitic patients

17 May 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt

17 May 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31685-6

17 May 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=449438

2 July 2022

1 reference